Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ferroportin-1 (FPN or SLC40A1) is the only known iron exporter in mammals, encoded by the SLC40A1 gene[1][2][3][5][7][8]. It is a transmembrane protein primarily responsible for transporting iron from enterocytes, hepatocytes, and reticuloendothelial macrophages into the bloodstream, thus regulating systemic iron balance. FPN function is tightly regulated by the hormone hepcidin: when plasma iron is high, hepcidin binds FPN, triggering its degradation and thereby reducing iron export; when iron is low, decreased hepcidin leads to increased FPN at cell surfaces and thus greater iron release. Mutations in SLC40A1 cause hereditary hemochromatosis type 4 (ferroportin disease), characterized by pathological iron overload and end-organ damage[3][4]. Ferroportin also plays a role in preventing iron-mediated oxidative damage and in controlling ferroptosis, a form of cell death linked to various diseases including cancer[2]. FPN is part of the major facilitator superfamily and is expressed in tissues inherently involved in iron absorption and storage, such as intestinal enterocytes, macrophages, hepatocytes, and placental syncytiotrophoblasts[1][8].
Hepcidin binds to ferroportin, causing its internalization and degradation, thus reducing iron efflux. Modulation of the hepcidin–ferroportin interaction to restore or inhibit iron export.
1 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ferroportin-1 (FPN (also SLC40A1)).